These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 22234350)
1. Genetic polymorphisms of the transcription factor NFATc4 and development of new-onset diabetes after transplantation in Hispanic kidney transplant recipients. Chen Y; Sampaio MS; Yang JW; Min D; Hutchinson IV Transplantation; 2012 Feb; 93(3):325-30. PubMed ID: 22234350 [TBL] [Abstract][Full Text] [Related]
2. Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus. Elens L; Sombogaard F; Hesselink DA; van Schaik RH; van Gelder T Pharmacogenet Genomics; 2013 Dec; 23(12):649-57. PubMed ID: 24113216 [TBL] [Abstract][Full Text] [Related]
3. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation. Porrini E; Delgado P; Alvarez A; Cobo M; Pérez L; González-Posada JM; Hortal L; Gallego R; García JJ; Checa M; Morales A; Salido E; Hernández D; Torres A Nephrol Dial Transplant; 2008 Apr; 23(4):1436-41. PubMed ID: 18029372 [TBL] [Abstract][Full Text] [Related]
4. Genetic and clinical risk factors of new-onset diabetes after transplantation in Hispanic kidney transplant recipients. Yang J; Hutchinson II; Shah T; Min DI Transplantation; 2011 May; 91(10):1114-9. PubMed ID: 21544032 [TBL] [Abstract][Full Text] [Related]
5. Association of genetic polymorphisms of interleukins with new-onset diabetes after transplantation in renal transplantation. Kim YG; Ihm CG; Lee TW; Lee SH; Jeong KH; Moon JY; Chung JH; Kim SK; Kim YH Transplantation; 2012 May; 93(9):900-7. PubMed ID: 22377791 [TBL] [Abstract][Full Text] [Related]
6. Pretransplant risk factors for new-onset diabetes mellitus after transplant in pediatric liver transplant recipients. Kuo HT; Lau C; Sampaio MS; Bunnapradist S Liver Transpl; 2010 Nov; 16(11):1249-56. PubMed ID: 21031540 [TBL] [Abstract][Full Text] [Related]
7. Magnesemia in renal transplant recipients: relation with immunosuppression and posttransplant diabetes. Osorio JM; Bravo J; Pérez A; Ferreyra C; Osuna A Transplant Proc; 2010 Oct; 42(8):2910-3. PubMed ID: 20970568 [TBL] [Abstract][Full Text] [Related]
8. Hypomagnesemia and the risk of new-onset diabetes after liver transplantation. Van Laecke S; Desideri F; Geerts A; Van Vlierberghe H; Berrevoet F; Rogiers X; Troisi R; de Hemptinne B; Vanholder R; Colle I Liver Transpl; 2010 Nov; 16(11):1278-87. PubMed ID: 21031543 [TBL] [Abstract][Full Text] [Related]
9. KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients. Tavira B; Coto E; Díaz-Corte C; Ortega F; Arias M; Torres A; Díaz JM; Selgas R; López-Larrea C; Campistol JM; Ruiz-Ortega M; Alvarez V; Clin Transplant; 2011; 25(3):E284-91. PubMed ID: 21355884 [TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation. Roland M; Gatault P; Doute C; Büchler M; Al-Najjar A; Barbet C; Chatelet V; Marlière JF; Nivet H; Lebranchu Y; Halimi JM Transpl Int; 2008 Jun; 21(6):523-30. PubMed ID: 18266773 [TBL] [Abstract][Full Text] [Related]
14. Renal resistive index as a new independent risk factor for new-onset diabetes mellitus after kidney transplantation. Mutinelli-Szymanski P; Caille A; Tranquart F; Al-Najjar A; Büchler M; Barbet C; Marlière JF; Gatault P; Réault J; Boin C; Chatelet V; Laouad I; Nivet H; Lebranchu Y; Halimi JM Transpl Int; 2012 Apr; 25(4):464-70. PubMed ID: 22364312 [TBL] [Abstract][Full Text] [Related]
15. Early prediction of new-onset diabetes mellitus by fifth-day fasting plasma glucose, pulse pressure, and proteinuria. Rodrigo E; Santos L; Piñera C; Quintanar JA; Ruiz JC; Fernández-Fresnedo G; Palomar R; Gómez-Alamillo C; Arias M Transplant Proc; 2011; 43(6):2208-10. PubMed ID: 21839235 [TBL] [Abstract][Full Text] [Related]
16. Predictors of new onset diabetes after renal transplantation. Joss N; Staatz CE; Thomson AH; Jardine AG Clin Transplant; 2007; 21(1):136-43. PubMed ID: 17302602 [TBL] [Abstract][Full Text] [Related]
17. Genetic variations in a Sestrin2/Sestrin3/mTOR Axis and development of new-onset diabetes after kidney transplantation. Luu D; Shah T; Sakharkar P; Min DI Transpl Immunol; 2023 Dec; 81():101947. PubMed ID: 37918578 [TBL] [Abstract][Full Text] [Related]
18. Predictors of new onset of diabetes after transplantation in stable renal recipients. Shehab-Eldin W; Shoker A Nephron Clin Pract; 2008; 110(1):c1-9. PubMed ID: 18654089 [TBL] [Abstract][Full Text] [Related]
19. Clinical and genetic risk factors for new-onset diabetes mellitus after transplantation (NODAT) in major transplant centres in Malaysia. Guad RM; Taylor-Robinson AW; Wu YS; Gan SH; Zaharan NL; Basu RC; Liew CSL; Wan Md Adnan WAH BMC Nephrol; 2020 Sep; 21(1):388. PubMed ID: 32894076 [TBL] [Abstract][Full Text] [Related]
20. Tacrolimus and angiotensin receptor blockers associated with changes in serum adiponectin level in new-onset diabetes after renal transplantation: single-center cross-sectional analysis. Nishimura K; Kishikawa H; Kato T; Kobayashi Y; Fujii N; Takahara S; Ichikawa Y Transpl Int; 2009 Jul; 22(7):694-701. PubMed ID: 19254242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]